WallStreetZenWallStreetZen

NASDAQ: SNY
Sanofi Stock

$47.29-0.56 (-1.17%)
Updated Mar 1, 2024
SNY Price
$47.29
Fair Value Price
$148.81
Market Cap
$119.62B
52 Week Low
$42.63
52 Week High
$57.82
P/E
20.41x
P/B
1.5x
P/S
2.41x
PEG
0.57x
Dividend Yield
4.02%
Revenue
$49.94B
Earnings
$6.00B
Gross Margin
69.3%
Operating Margin
17.9%
Profit Margin
11.6%
Debt to Equity
0.7
Operating Cash Flow
$11B
Beta
0.52
Next Earnings
Apr 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A

SNY Overview

Sanofi is a multinational pharmaceutical and healthcare company. The company provides specialty care products, including human monoclonal antibodies, products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, rare blood disorders, diabetes, and cardiovascular and established prescription products. It also has pharmaceutical products and vaccines in developmental stage. The company was founded in 1973 and is headquartered in Paris, France.

Zen Score

Industry Average (43)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SNY scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SNY ($47.29) is undervalued by 68.22% relative to our estimate of its Fair Value price of $148.81 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SNY ($47.29) is significantly undervalued by 68.22% relative to our estimate of its Fair Value price of $148.81 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SNY ($47.29) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more SNY due diligence checks available for Premium users.

Be the first to know about important SNY news, forecast changes, insider trades & much more!

SNY News

Valuation

SNY fair value

Fair Value of SNY stock based on Discounted Cash Flow (DCF)
Price
$47.29
Fair Value
$148.81
Undervalued by
68.22%
SNY ($47.29) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SNY ($47.29) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SNY ($47.29) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SNY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
20.41x
Industry
153.3x
Market
36.17x
SNY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SNY is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

SNY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.5x
Industry
6.1x
SNY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SNY price to earnings growth (PEG)

For valuing profitable companies with growth potential
SNY is good value based... subscribe to Premium to read more.
PEG Value Valuation

SNY's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
SNY's Earnings (EBIT) of $8.94B... subscribe to Premium to read more.
Interest Coverage Financials
SNY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$140.5B
Liabilities
$57.9B
Debt to equity
0.7
SNY's short-term assets ($32.96B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SNY's short-term assets ($32.96B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SNY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SNY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
SNY's operating cash flow ($11.03B)... subscribe to Premium to read more.
Debt Coverage Financials

SNY vs General Drug Manufacturer Stocks

TickerMarket Cap1d %P/EP/B
SNY$119.62B-1.17%20.41x1.50x
BMY$102.91B+0.28%13.12x3.50x
GILD$90.08B+0.29%15.93x3.95x
PFE$150.15B+0.11%69.97x1.69x
AMGN$150.23B+2.37%22.32x24.11x

Sanofi Stock FAQ

What is Sanofi's quote symbol?

(NASDAQ: SNY) Sanofi trades on the NASDAQ under the ticker symbol SNY. Sanofi stock quotes can also be displayed as NASDAQ: SNY.

If you're new to stock investing, here's how to buy Sanofi stock.

What is the 52 week high and low for Sanofi (NASDAQ: SNY)?

(NASDAQ: SNY) Sanofi's 52-week high was $57.82, and its 52-week low was $42.63. It is currently -18.21% from its 52-week high and 10.93% from its 52-week low.

How much is Sanofi stock worth today?

(NASDAQ: SNY) Sanofi currently has 1,264,799,969 outstanding shares. With Sanofi stock trading at $47.29 per share, the total value of Sanofi stock (market capitalization) is $119.62B.

Sanofi stock was originally listed at a price of $29.77 in Jul 1, 2002. If you had invested in Sanofi stock at $29.77, your return over the last 21 years would have been 58.85%, for an annualized return of 2.23% (not including any dividends or dividend reinvestments).

How much is Sanofi's stock price per share?

(NASDAQ: SNY) Sanofi stock price per share is $47.29 today (as of Mar 1, 2024).

What is Sanofi's Market Cap?

(NASDAQ: SNY) Sanofi's market cap is $119.62B, as of Mar 2, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Sanofi's market cap is calculated by multiplying SNY's current stock price of $47.29 by SNY's total outstanding shares of 1,264,799,969.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.